Treatment of Nodular Lymphocyte–Predominant Hodgkin Lymphoma (NLPHL)

For information about the treatments listed below, see the Treatment Option Overview section.

Treatment of NLPHL in adults may include the following:

• Watchful waiting or active surveillance.
• Radiation therapy to the areas of the body with cancer, for patients with early-stage NLPHL.
• Chemotherapy, for patients with advanced-stage NLPHL.
• Targeted therapy with a monoclonal antibody (rituximab).